Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Craddock

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
Leukemia|July 15, 2015
Acquired isodisomy on chromosome 13 at diagnosis results in impaired overall survival in patients with FLT3-ITD mutant acute myeloid leukaemiaJ C T Loke, S Akiki, J Borrow, et al.
Bone Marrow Transplantation|July 10, 2012
The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMTS Giebel, M Labopin, M Mohty, et al.
Leukemia|August 27, 2010
Analysis of BCR-ABL1 tyrosine kinase domain mutational spectra in primitive chronic myeloid leukemia cells suggests a unique mutator phenotypeH Grant, X Jiang, J Stebbing, et al.
Bone Marrow Transplantation|June 2, 2015
Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMTJ R Passweg, M Labopin, J Cornelissen, et al.
Molecular Psychiatry|June 3, 2015
Connectome-wide network analysis of youth with Psychosis-Spectrum symptomsT D Satterthwaite, S N Vandekar, D H Wolf, et al.
Bone Marrow Transplantation|September 15, 2015
In patients older than 55 years with AML in first CR, should we search for a matched unrelated donor when an old sibling donor is available?R Peffault de Latour, M Labopin, J Cornelissen, et al.
Bone Marrow Transplantation|November 8, 2016
Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMTM Robin, R Porcher, W Zinke-Cerwenka, et al.
Bone Marrow Transplantation|July 6, 2017
Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMTM Robin, R Porcher, W Zinke-Cerwenka, et al.
Plos One|August 24, 2021
Development of a standardized MRI protocol for pancreas assessment in humansJohn Virostko, Richard C Craddock, Jonathan M Williams, et al.
Leukemia|December 11, 2012
Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasiaC Craddock, L Quek, N Goardon, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Leukemia|July 15, 2015
Acquired isodisomy on chromosome 13 at diagnosis results in impaired overall survival in patients with FLT3-ITD mutant acute myeloid leukaemiaJ C T Loke, S Akiki, J Borrow, et al.
Bone Marrow Transplantation|July 10, 2012
The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMTS Giebel, M Labopin, M Mohty, et al.
Leukemia|August 27, 2010
Analysis of BCR-ABL1 tyrosine kinase domain mutational spectra in primitive chronic myeloid leukemia cells suggests a unique mutator phenotypeH Grant, X Jiang, J Stebbing, et al.
Bone Marrow Transplantation|June 2, 2015
Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMTJ R Passweg, M Labopin, J Cornelissen, et al.
Molecular Psychiatry|June 3, 2015
Connectome-wide network analysis of youth with Psychosis-Spectrum symptomsT D Satterthwaite, S N Vandekar, D H Wolf, et al.
Bone Marrow Transplantation|September 15, 2015
In patients older than 55 years with AML in first CR, should we search for a matched unrelated donor when an old sibling donor is available?R Peffault de Latour, M Labopin, J Cornelissen, et al.
Bone Marrow Transplantation|November 8, 2016
Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMTM Robin, R Porcher, W Zinke-Cerwenka, et al.
Bone Marrow Transplantation|July 6, 2017
Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMTM Robin, R Porcher, W Zinke-Cerwenka, et al.
Plos One|August 24, 2021
Development of a standardized MRI protocol for pancreas assessment in humansJohn Virostko, Richard C Craddock, Jonathan M Williams, et al.
Leukemia|December 11, 2012
Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasiaC Craddock, L Quek, N Goardon, et al.
Pageof 13